Viewing Study NCT00169195

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 2:03 PM

Ignite Modification Date: 2026-02-26 @ 8:11 PM

Study NCT ID: NCT00169195

Status: COMPLETED

Last Update Posted: 2015-09-02

First Post: 2005-09-12

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma

Sponsor: Lymphoma Study Association

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module